Siremadlin Monotherapy and in Combination with Donor Lymphocyte Infusion for Patients with Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation Who Are in Complete Remission but at High Risk for Relapse

被引：2
|
作者：
Zeiser, Robert [1 ,2 ]
Schmid, Christoph [3 ,4 ]
Alatrash, Gheath [5 ,6 ]
Ram, Ron [7 ,8 ]
Wu, Yuan [9 ]
Weber, Hans-Jochen Jochen [10 ]
Grzesiak, Stephanie [11 ]
Eldjerou, Lamis K. [12 ]
Craddock, Charles [13 ]
机构：
[1] Univ Med Ctr Freiburg, Freiburg, Germany
[2] Univ Freiburg, Fac Med, Med Ctr, Dept Med 1, Freiburg, Germany
[3] Augsburg Univ Hosp, Dept Hematol & Oncol Stem Cell Transplantat, Augsburg, Germany
[4] Med Fac, Augsburg, Germany
[5] Univ Texas MD Anderson Canc Ctr, Dept Hematopoiet Biol & Malignancy, Pearland, TX USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[7] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, BMT Unit, Tel Aviv, Israel
[8] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[9] Novartis Pharmaceut, Oncol Analyt, Basel, Switzerland
[10] Novartis Pharma AG, Basel, Switzerland
[11] Novartis Pharmaceut, Basel, Switzerland
[12] Novartis Pharmaceut, E Hanover, NJ USA
[13] Univ Hosp Birmingham NHS Trust, Queen Elizabeth Med Ctr, Dept Haematol, Birmingham, W Midlands, England
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-167011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8944 / 8945
页数：2
相关论文
共 50 条
  • [21] A Phase I Study Of Azacitidine After Donor Lymphocyte Infusion For Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
    Ghobadi, Armin
    Fiala, Mark A.
    Abboud, Camille N.
    Cashen, Amanda F.
    Eissenberg, Linda
    Graubert, Timothy
    Jacoby, Meagan A.
    Pusic, Iskra
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith E.
    Tomasson, Michael H.
    Uy, Geoffrey L.
    Vij, Ravi
    Walter, Matthew J.
    DiPersio, John F.
    Westervelt, Peter
    BLOOD, 2013, 122 (21)
  • [22] Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia
    Tsirigotis, Panagiotis
    Gkirkas, Konstantinos
    Kitsiou, Vassiliki
    Chondropoulos, Spiros
    Athanassiades, Theofilos
    Thomopoulos, Thomas
    Tsirogianni, Alexandra
    Stamouli, Maria
    Karagiannidi, Aggeliki
    Siafakas, Nikolaos
    Pappa, Vassiliki
    Nagler, Arnon
    CANCERS, 2021, 13 (11)
  • [23] Factors affecting survival in acute leukemia with donor lymphocyte infusion in the first relapse after allogeneic stem cell transplantation
    Kurnaz, Fatih
    Sahin, Cem
    Kaynar, Leylagul
    Pala, Cigdem
    Sivgin, Serdar
    Altuntas, Fevzi
    Eser, Bulent
    Cetin, Mustafa
    Unal, Ali
    JOURNAL OF BUON, 2016, 21 (01): : 227 - 234
  • [24] Efficacy and safety of preemptive and prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high risk acute myeloid leukemia and myelodysplastic syndromes
    Velazquez, Filippini G.
    Pfeiffer, T.
    Hirschbuehl, K.
    Schmaelter, A. K.
    Waidhauser, J.
    Rank, A.
    Trepel, M.
    Schmid, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 145 - 145
  • [25] Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation
    Au, WY
    Lie, AKW
    Lee, CK
    Liang, R
    Kwong, YL
    BONE MARROW TRANSPLANTATION, 1999, 23 (11) : 1201 - 1203
  • [26] Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation
    WY Au
    AKW Lie
    CK Lee
    R Liang
    YL Kwong
    Bone Marrow Transplantation, 1999, 23 : 1201 - 1203
  • [27] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    Kordelas, L.
    Buttkereit, U.
    Lindemann, M.
    Koldehoff, M.
    Klisanin, V.
    Horn, P. A.
    Fleischhauer, K.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2017, 52 (12) : 1668 - 1670
  • [28] Extramedullary Leukemia Relapse In Patients With Acute Myeloid Leukemia Allogeneic Stem Cell Transplantation: Risk Factors and Prognosis
    Gupta, Vinay
    Gundabolu, Krishna
    Gonsalves, Wilson I.
    Litzow, Mark R.
    Hogan, William J.
    Gangat, Naseema
    Patnaik, Mrinal M.
    BLOOD, 2013, 122 (21)
  • [29] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    L Kordelas
    U Buttkereit
    M Lindemann
    M Koldehoff
    V Klisanin
    P A Horn
    K Fleischhauer
    D W Beelen
    Bone Marrow Transplantation, 2017, 52 : 1668 - 1670
  • [30] Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: Are We Closer to Knowing Who Needs It?
    Lazaros J. Lekakis
    Brenda W. Cooper
    Marcos G. de Lima
    Current Hematologic Malignancy Reports, 2014, 9 : 128 - 137
12345